Tuesday, 27 October 2026European Markets

NORSKE SKOG And ALTRI SGPS Have A High Dividend Yield And Return On Equity In The Paper & Paper Products Industry.

Loading stream...

(VIANEWS) - NORSKE SKOG (NSKOG.OL) is among this list of stock assets with the highest dividend rate and return on equity on the Paper & Paper Products industry.

Financial Asset Price Forward Dividend Yield Return on Equity
NORSKE SKOG (NSKOG.OL) kr41.14 19.05% 19.82%
ALTRI SGPS (ALTR.LS) €4.45 5.6% 24.5%

Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. NORSKE SKOG (NSKOG.OL)

19.05% Forward Dividend Yield and 19.82% Return On Equity

Norske Skog ASA produces and sells newsprint and magazine papers. It operates in two segments, Publication Paper Europe, and Publication Paper Australasia. The company offers standard newsprint and other papers; and magazine paper comprising super calendared and lightweight coated magazine paper. Its products are primarily used in newspapers and magazines, catalogues, advertising materials, inserts/flyers, supplements, free-sheets, directories, direct mail, and book papers. The company operates in Norway, rest of Europe, North America, Australasia, Asia, and Africa. Norske Skog ASA was founded in 1962 and is headquartered in Oslo, Norway.

Earnings Per Share

As for profitability, NORSKE SKOG has a trailing twelve months EPS of kr9.75.

PE Ratio

NORSKE SKOG has a trailing twelve months price to earnings ratio of 4.22. Meaning, the purchaser of the share is investing kr4.22 for every norwegian krone of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 19.82%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

NORSKE SKOG's EBITDA is 26.96.

More news about NORSKE SKOG.

2. ALTRI SGPS (ALTR.LS)

5.6% Forward Dividend Yield and 24.5% Return On Equity

Altri, SGPS, S.A. produces and sells cellulosic fibers and energy in Portugal and internationally. The company produces pulp products for various application including production of paper, tissue, and printing and writing papers; and dissolving pulp for use of textile production. It is also involved timber commercialization; forest management; production of forest-based renewable energy, such as industrial cogeneration from black liquor and biomass; real estate activities; and production of plants in nurseries, as well as the provision of services related with forests and landscapes. The company was incorporated in 2005 and is headquartered in Porto, Portugal.

Earnings Per Share

As for profitability, ALTRI SGPS has a trailing twelve months EPS of €0.54.

PE Ratio

ALTRI SGPS has a trailing twelve months price to earnings ratio of 8.24. Meaning, the purchaser of the share is investing €8.24 for every euro of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 24.5%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 29.2%, now sitting on 941.08M for the twelve trailing months.

Volatility

ALTRI SGPS's last week, last month's, and last quarter's current intraday variation average was 1.36%, 0.22%, and 1.07%.

ALTRI SGPS's highest amplitude of average volatility was 1.63% (last week), 1.41% (last month), and 1.07% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ALTRI SGPS's stock is considered to be oversold (<=20).

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on May 16, 2023, the estimated forward annual dividend rate is 0.25 and the estimated forward annual dividend yield is 5.6%.

More news about ALTRI SGPS.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com